The Amazing Son in Law The Charismatic Charlie Wade

Chapter 3775

The White House wanted the patent for the JX Renewing Pill, which, in Smith's opinion, was both unexpected and justified.

Once the health department reported such information to the White House, they naturally could not let go of this good opportunity.

However, whether they can get the patent in hand, that is not for them to decide.

This kind of medicine, like a super money printing machine, as long as it is in the hands of visionary people, it is impossible to sell the patent.

But Smith also did not throw cold water on the other side, but quickly agreed, saying, "After I meet the other party's head, I will try to promote this matter."

"However, such a big thing, I'm afraid I can't handle it alone, the White House should send a few negotiators over?"

The health minister immediately denied: "This kind of thing is not good for the White House to come out directly,"

"It will make people think that the White House is intending to control the medical field, once the world's governments have begun to intervene, this matter is not good to promote."

instructed: "You go over this time, first privately explore the other side of the wind, if the other side is interested in making a bid, just fix the money, I will give Johnson & Johnson's head a call,

staggered, thinking: "The White House operating this kind of thing, indeed

alone, once J&J got the patent

party continued to exhort him: "Smith, you must do everything possible to promote this matter to land, once

at least a few percentage points of sales a year to play the relationship,

not help

to market, a year of 100 billion dollars in sales easily,

dollars to play the relationship, even if they are just

help but get excited and said: "I will do my best

party satisfied with a response, and said: "Smith, from the White House side there are instructions, if the patent for this drug can not be attained, you must crack the

be devastating to the credibility of our entire pharmaceutical patent system, is it not too risky

kind of thing we certainly will not do it ourselves

our holding company in India to produce it, anyway, there it is easy

the